Article
High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism.
International immunology - 1 Aug 2012
Mishima Yuji, Terui Yasuhito, Mishima Yuko, Kuniyoshi Ryoko, Matsusaka Satoshi, Mikuniya Mariko, Kojima Kiyotsugu, Hatake Kiyohiko
Abstract excerpt
The anti-CD20 chimeric monoclonal antibody rituximab mediates cytotoxicity in malignant B cells via multiple mechanisms, including complement-dependent cytotoxicity (CDC), antibody-dependent cellular cytotoxicity (ADCC) and direct induction of apoptosis. To optimize treatment of non-Hodgkin's lymphoma, a fuller understanding of these mechanisms and their relative contributions to clinical efficacy is required....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
